The presence of pesticide in water resources is a topical issue in France as in many other countries. Resources can be contaminated by current-used pesticides and their metabolites but also by ...molecules banned 50 years ago. The number of reported studies on the impact of these substances on human health and environment increases every day. Currently, pesticides and their relevant degradation products are subjected to the European regulation for water intended for human consumption. It sets an individual quality limit of 0.1 μg/L, and another of 0.5 μg/L for the sum of their concentrations. The constant improvement of analytical methods allows laboratories to detect pesticides, at lower and lower concentrations but also more and more metabolites. However, regulation does not provide a national indicative metabolites list to be monitored. Each regional health agency offers their own list based on local agricultural practices and quantities of pesticides sold. This article reports a prioritization method allowing to identify new metabolites to be monitored in water resources, along drinking water treatment plants and in treated water; it describes its application in France in order to anticipate possible non-compliance with raw water and treated water and to provide solutions upstream of changes in sanitary control. This methodology has been developed to rank pesticides and to select the corresponding metabolites by combining three main criteria: use (sale and type of use), toxicity, and environmental fate (based on physical and chemical properties). Prioritization method was applied to four families of pesticides: carbamates, organophosphorus compounds, phenylpyrazoles and neonicotinoids, for which there is a real lack of knowledge as regards the occurrence of their metabolites in metropolitan France. 146 pesticides have been prioritized. The first 50 molecules were considered allowing the identification of 72 metabolites to be monitored in water resources and along drinking water treatment plants.
Display omitted
•A prioritization methodology has been developed for pesticides and their metabolites.•Carbamates, organophosphates, phenylpyrazoles and neonicotinoids were selected.•146 molecules were prioritized based on use, toxicity and environmental fate.
In this article, a dataset from a collaborative non-target screening trial organised by the NORMAN Association is used to review the state-of-the-art and discuss future perspectives of non-target ...screening using high-resolution mass spectrometry in water analysis. A total of 18 institutes from 12 European countries analysed an extract of the same water sample collected from the River Danube with either one or both of liquid and gas chromatography coupled with mass spectrometry detection. This article focuses mainly on the use of high resolution screening techniques with target, suspect, and non-target workflows to identify substances in environmental samples. Specific examples are given to emphasise major challenges including isobaric and co-eluting substances, dependence on target and suspect lists, formula assignment, the use of retention information, and the confidence of identification. Approaches and methods applicable to unit resolution data are also discussed. Although most substances were identified using high resolution data with target and suspect-screening approaches, some participants proposed tentative non-target identifications. This comprehensive dataset revealed that non-target analytical techniques are already substantially harmonised between the participants, but the data processing remains time-consuming. Although the objective of a “fully-automated identification workflow” remains elusive in the short term, important steps in this direction have been taken, exemplified by the growing popularity of suspect screening approaches. Major recommendations to improve non-target screening include better integration and connection of desired features into software packages, the exchange of target and suspect lists, and the contribution of more spectra from standard substances into (openly accessible) databases.
Graphical Abstract
Matrix of identification approach versus identification confidence
The increasingly frequent detection of resistant organic micropollutants in waters calls for better treatment of these molecules that are recognized to be dangerous for human health and the ...environment. As an alternative to conventional adsorbent material such as activated carbon, silica-clay nanocomposites were synthesized for the removal of pharmaceuticals in contaminated water. Their efficiency with respect to carbamazepine, ciprofloxacin, danofloxacin, doxycycline, and sulfamethoxazole was assessed in model water and real groundwater spiked with the five contaminants. Results showed that the efficacy of contaminant removal depends on the chemical properties of the micropollutants. Among the adsorbents tested, the nanocomposite made of 95% clay and 5% SiO
2
NPs was the most efficient and was easily recovered from solution after treatment compared with pure clay, for example. The composite is thus a good candidate in terms of operating costs and environmental sustainability for the removal of organic contaminants.
Abstract
Twenty-seven triazines and metabolites were screened throughout six advanced drinking water treatment plants (DWTP) in France and their respective resources. Seven molecules were quantified ...in raw waters with a maximum concentration of 91 ng/L reached for desethyl-atrazine. No metabolites generated through advanced degradation pathways were quantified. Concentration profiles for five DWTP treating ground or surface waters were very similar and remained stable over time. Only one DWTP treating groundwater presented differences between sampling periods due to variations in wells' operations. As expected, most treatment units (settling, ozonation, nitrification, sand filtration, chlorination) did not allow for efficient removal of these micropollutants. Adsorption on granular or powdered activated carbon (PAC) was highlighted as the best available technology for the majority of quantified compounds. Combined PAC and ultrafiltration treatment was especially adapted for the removal of hydroxy-atrazine, one of the most refractory components evaluated during this study. Indeed, among quantified pesticides, only hydroxy-atrazine and desethyl-deisopropyl-atrazine were measured in treated water, with concentrations below 12 ng/L.
The removal of 13 polycyclic aromatic hydrocarbons, 7 polychlorobiphenyls and nonylphenol was measured during the continuous anaerobic digestion of five different sludge samples. The reactors were ...fed with one of the following: primary/secondary sludge (PS/SS), thermally treated PS, cellulose-added SS, or SS augmented with dissolved and colloidal matter (DCM). These various feeding conditions induced variable levels of micropollutant bioavailability (assumed to limit their biodegradation) and overall metabolism (supposed to be linked to micropollutant metabolism throughout co-metabolism). On the one hand, overall metabolism was higher with secondary sludge than with primary and the same was observed for micropollutant removal. However, when overall metabolism was enhanced thanks to cellulose addition, a negative influence on micropollutant removal was observed. This suggests that either the co-metabolic synergy would be linked to a specific metabolism or co-metabolism was not the limiting factor in this case. On the other hand, micropollutant bioavailability was presumably diminished by thermal treatment and increased by DCM addition. In both cases, micropollutant removal was reduced. These results suggest that neither overall metabolism nor bioavailability would absolutely limit micropollutant removal. Each phenomenon might alternatively predominate depending on the feed characteristics.
Les hydrocarbures aromatiques polycycliques (HAP) sont des composés organiques présents dans l’ensemble des compartiments environnementaux. Dans l’atmosphère, leurs sources sont à la fois naturelles ...(feux de biomasse, éruptions volcaniques) et anthropiques (industrie, transport, chauffage résidentiel). Une fois émis, sous forme gazeuse ou adsorbés à la surface de particules atmosphériques, les HAP sont susceptibles d’être impliqués dans des processus physico-chimiques tels que la photodégradation et/ou des réactions d’oxydation avec différentes espèces radicalaires. Du fait de leur toxicité avérée, ces composés font l’objet de différentes réglementations, législations françaises et européennes. Concernant le compartiment atmosphérique, seul le benzo(a)pyrène présente aujourd’hui des seuils d’émission à respecter. Afin de faire évoluer ces textes et de mettre en place des mesures de réduction d’émissions, diverses approches ont été développées dans le but de différencier leurs sources dans l’atmosphère. L’approche moléculaire, basée sur les profils moléculaires et les rapports de concentrations, permet d’apporter des informations quant à leurs origines. En revanche, elle souffre de biais induits par les conditions de formation des HAP (température, conditions environnementales…) et par les processus physico-chimiques dans lesquels ils sont impliqués. L’objectif principal de ce travail est de mettre en place une méthodologie de traçage de sources des HAP particulaires par une approche isotopique. Le développement du protocole analytique a été réalisé pour déterminer la composition isotopique moléculaire des HAP particulaires par GC/C/IRMS. Il a été montré que la réactivité des HAP sous l’action d’oxydants (O3, NO2, OH) et/ou de la lumière solaire n’induisait pas de variation significative de la composition isotopique moléculaire des HAP. Cette méthodologie a ainsi pu être appliquée sur des échantillons naturels, prélevés sur des sites caractérisés par des sources spécifiques. Il a été montré que les 13C/12C des HAP, en complément de données moléculaires, permettent de différencier les origines de ces composés. Par exemple, les caractéristiques moléculaires et isotopiques de HAP issus de la combustion de plusieurs espèces de bois d’origine méditerranéenne ont été déterminées en appliquant cette méthodologie à des échantillons collectés directement à l’émission. Enfin, dans le cadre de l’étude de la pollution et de ses impacts dans le Bassin d’Arcachon, les apports atmosphériques en HAP ont été mesurés par l’approche moléculaire couplée à d’autres outils (rétrotrajectoires, oxydants, roses des vents…) afin de compléter le diagnostic environnemental.
Polycyclic Aromatic Hydrocarbons (PAH) are carcinogenic compounds, present in all the compartments of the Environment. In the atmosphere, their sources are both from natural (biomass burning, volcanic emissions...) and anthropogenic (transport, industry, residential heating...) origins. Once emitted in the atmosphere, PAH are distributed between the gaseous or particulate phases and may be involved in different physico-chemical processes such as photodegradation, radical-initiated oxidations... Due to their carcinogenicity, PAH emissions are nowadays subjected to various regulations from France and more largely, European Union. In the atmosphere, benzo(a)pyrene has been selected as representative of the PAHs because of its high toxicity. In order to improve regulations involving emission reductions, several methodologies have been developed to perform source apportionment. The most commonly used in the literature is the molecular approach, based on molecular profiles and particular ratios. Nevertheless, conditions of PAH formation and physico-chemical processes affect these characteristic values. The main objective of this work was to develop a new methodology of particulate-PAH source tracking based on the molecular isotopic composition. The development of analytical procedure was performed to determine 13C/12C of PAHs by GC/C/IRMS. The study of the impact of PAH reactivity in the presence of O3, NO2, OH and/or solar radiations shows that no significant isotopic fractionation is induced on their isotopic compositions. Molecular isotopic approach was applied on natural particles, collected at different specific sites: 13C/12C of PAHs and molecular data allow differentiating particulate-PAH sources. Therefore, determinations of molecular and isotopic characteristics have been undertaken by applying this methodology on particulate-PAHs emitted during the combustion of fifteen Mediterranean woods. Finally, molecular approach coupled with different parameters (back-trajectories, oxidant concentrations, wind roses...) enables to measure the levels of PAH concentrations in the atmosphere in order to evaluate their impacts as a source of pollution in the Arcachon Bay.
IMPORTANCE: Coronavirus disease 2019 (COVID-19) is associated with severe lung damage. Corticosteroids are a possible therapeutic option. OBJECTIVE: To determine the effect of hydrocortisone on ...treatment failure on day 21 in critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and acute respiratory failure. DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized double-blind sequential trial conducted in France, with interim analyses planned every 50 patients. Patients admitted to the intensive care unit (ICU) for COVID-19–related acute respiratory failure were enrolled from March 7 to June 1, 2020, with last follow-up on June 29, 2020. The study intended to enroll 290 patients but was stopped early following the recommendation of the data and safety monitoring board. INTERVENTIONS: Patients were randomized to receive low-dose hydrocortisone (n = 76) or placebo (n = 73). MAIN OUTCOMES AND MEASURES: The primary outcome, treatment failure on day 21, was defined as death or persistent dependency on mechanical ventilation or high-flow oxygen therapy. Prespecified secondary outcomes included the need for tracheal intubation (among patients not intubated at baseline); cumulative incidences (until day 21) of prone position sessions, extracorporeal membrane oxygenation, and inhaled nitric oxide; Pao2:Fio2 ratio measured daily from day 1 to day 7, then on days 14 and 21; and the proportion of patients with secondary infections during their ICU stay. RESULTS: The study was stopped after 149 patients (mean age, 62.2 years; 30.2% women; 81.2% mechanically ventilated) were enrolled. One hundred forty-eight patients (99.3%) completed the study, and there were 69 treatment failure events, including 11 deaths in the hydrocortisone group and 20 deaths in the placebo group. The primary outcome, treatment failure on day 21, occurred in 32 of 76 patients (42.1%) in the hydrocortisone group compared with 37 of 73 (50.7%) in the placebo group (difference of proportions, –8.6% 95.48% CI, –24.9% to 7.7%; P = .29). Of the 4 prespecified secondary outcomes, none showed a significant difference. No serious adverse events were related to the study treatment. CONCLUSIONS AND RELEVANCE: In this study of critically ill patients with COVID-19 and acute respiratory failure, low-dose hydrocortisone, compared with placebo, did not significantly reduce treatment failure (defined as death or persistent respiratory support) at day 21. However, the study was stopped early and likely was underpowered to find a statistically and clinically important difference in the primary outcome. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02517489
Abstract
Background
Although acute stroke is a leading cause of morbidity and mortality worldwide, data on outcomes of stroke patients requiring ICU admission are limited. We aimed to identify ...factors associated with a good neurological outcome (defined as a modified Rankin Scale score mRS of 0–2) 6 months after ICU admission.
Methods
We retrospectively studied consecutive patients who were admitted to the ICU of a French university-affiliated hospital between January 2014 and December 2018 and whose ICD-10 code indicated acute stroke. Patients with isolated subarachnoid hemorrhage or posttraumatic stroke were excluded.
Results
The 323 identified patients had a median age of 67 54.5–77 years; 173 (53.6%) were male. The main reasons for ICU admission were neurological failure (87%), hemodynamic instability (28.2%), acute respiratory failure (26%), and cardiac arrest (5.3%). At ICU admission, the Glasgow Coma Scale score was 6 4–10 and the SAPSII was 54 35–64. The stroke was hemorrhagic in 248 (76.8%) patients and ischemic in 75 (23.2%). Mechanical ventilation was required in 257 patients (79.6%). Six months after ICU admission, 61 (19.5%) patients had a good neurological outcome (mRS, 0–2), 50 (16%) had significant disability (mRS, 3–5), and 202 (64.5%) had died; 10 were lost to follow-up. By multivariable analysis, factors independently associated with not having an mRS of 0–2 at 6 months were older age (odds ratio, 0.93/year; 95% confidence interval, 0.89–0.96;
P
< 0.01) and lower Glasgow Coma Scale score at ICU admission (odds ratio, 1.23/point; 95% confidence interval, 1.07–1.40;
P
< 0.01).
Conclusions
Acute stroke requiring ICU admission carried a poor prognosis, with less than a fifth of patients having a good neurological outcome at 6 months. Age and depth of coma independently predicted the outcome.
Responding to social signals by expressing the correct behavior is not only challenged in autism but also in diseases with a high prevalence of autism, such as Prader-Willi syndrome. Clinical ...evidence suggests that aberrant prosocial behavior in patients can be regulated by intranasal oxytocin (OXT) or vasopressin (AVP). However, the neuronal mechanisms that underlie impaired behavioral responses in a socially aversive context, and how can they be corrected, remain largely unknown.
Using the Magel2 knockout mouse model of Prader-Willi syndrome (crossed with CRE-dependent transgenic lines), we devised optogenetic, physiological, and pharmacological strategies in a social fear conditioning paradigm. Pathway-specific roles of OXT and AVP signaling were investigated converging on the lateral septum (LS), a region that receives dense hypothalamic inputs.
OXT and AVP signaling promoted inhibitory synaptic transmission in the LS, the failure of which in Magel2 knockout mice disinhibited somatostatin (SST) neurons and disrupted social fear extinction. The source of OXT and AVP deficits mapped specifically in the supraoptic nucleus→LS pathway of Magel2 knockout mice with disrupted social fear extinction, which could be corrected by optogenetic or pharmacological inhibition of SST neurons in the LS. Interestingly, LS SST neurons also gated the expression of aggressive behavior, possibly as part of functional units that operate beyond local septal circuits.
SST cells in the LS play a crucial role in integration and expression of disrupted neuropeptide signals in autism, thereby altering the balance in expression of safety versus fear. Our results uncover novel mechanisms underlying dysfunction in a socially aversive context and provide a new framework for future treatments for autism spectrum disorder.
Intellectual and social disabilities are common comorbidities in adolescents and adults with MAGE family member L2 (MAGEL2) gene deficiency characterizing the Prader-Willi and Schaaf-Yang ...neurodevelopmental syndromes. The cellular and molecular mechanisms underlying the risk for autism in these syndromes are not understood. We asked whether vasopressin functions are altered by MAGEL2 deficiency and whether a treatment with vasopressin could alleviate the disabilities of social behavior. We used Magel2-knockout mice (adult males) combined with optogenetic or pharmacological tools to characterize disease modifications in the vasopressinergic brain system and monitor its impact on neurophysiological and behavioral functions. We found that the activation of vasopressin neurons and projections in the lateral septum were inappropriate for performing a social habituation/discrimination task. Mechanistically, the lack of vasopressin impeded the deactivation of somatostatin neurons in the lateral septum, which predicted social discrimination deficits. Correction of vasopressin septal content by administration or optogenetic stimulation of projecting axons suppressed the activity of somatostatin neurons and ameliorated social behavior. This preclinical study identified vasopressin in the lateral septum as a key factor in the pathophysiology of Magel2-related neurodevelopmental syndromes.
PDF
